Related Experiment Video
Updated: Jan 16, 2026

08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.3K
HSP60 and SARS-CoV-2: Les Liaisons Dangereuses
Adelaide Carista1, Melania Ionelia Gratie1, Francesco Cappello1
1Department of Biomedicine, Neurosciences and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.
Biology
|September 27, 2025
Summary
Heat shock protein 60 (Hsp60) is involved in COVID-19, causing inflammation and organ damage. Hsp60 may serve as a biomarker and therapeutic target for COVID-19 and related autoimmune conditions.
Area of Science:
- Immunology
- Molecular Biology
- Pathophysiology
Background:
- Heat shock protein 60 (Hsp60) is vital for cellular homeostasis and stress response.
- Emerging evidence links Hsp60 to COVID-19, impacting immune responses, inflammation, and endothelial function.
Purpose of the Study:
- To review the multifaceted roles of Hsp60 in COVID-19.
- To explore Hsp60's implications in disease progression, post-viral complications, and therapeutic strategies.
Main Methods:
- Literature review focusing on morpho-functional aspects of Hsp60 in COVID-19.
- Analysis of Hsp60's interactions with Toll-like receptors and SARS-CoV-2 proteins.
Main Results:
- Extracellular Hsp60 exacerbates inflammation and cytokine storms via Toll-like receptor interactions.
- Molecular mimicry between Hsp60 and SARS-CoV-2 proteins suggests a role in autoimmune disorders.
- Hsp60 is implicated in endothelial damage and thromboembolic events in severe COVID-19.
Conclusions:
- Hsp60 plays a significant role in COVID-19 pathogenesis, including immune modulation and organ damage.
- Hsp60 shows potential as a biomarker for disease severity and a therapeutic target.
- Structural similarities between Hsp60 and SARS-CoV-2 raise considerations for vaccine safety and anti-tumor immunity.
Related Concept Videos
Conjugated Proteins
27.5K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
27.5K
Single Nucleotide Polymorphisms-SNPs
17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K

